Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients

Journal of the American Society of Nephrology

Volumn 13, Issue 12, 2002, Pages 2983-2989

  Ng, Wan Fai ^a   Hernandez Fuentes, Maria ^a   Baker, Richard ^a   Chaudhry, Afzal ^a   Lechler, Robert I ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HLA DR ANTIGEN; INTERLEUKIN 2; MYCOPHENOLIC ACID; PREDNISOLONE; ALLOANTIBODY;

ADULT; AGED; ALPORT SYNDROME; ANIMAL CELL; ARTICLE; CHURG STRAUSS SYNDROME; CLONAL ANERGY; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; HEMOLYTIC UREMIC SYNDROME; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYELONEPHRITIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIVISION; DONOR; DRUG EFFECT; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE; T LYMPHOCYTE;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; CLONAL ANERGY; HUMANS; INTERLEUKIN-2; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MIDDLE AGED; REFERENCE VALUES; T-LYMPHOCYTES; TISSUE DONORS;

EID: 0036893161     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000042163.73539.D4     Document Type: Article

References (23)

1. Mason PD, Robinson CM, Lechler RI: Detection of donor-specific hyporesponsiveness following late failure of human renal allografts. Kidney Int 50: 1019-1025, 1996
2. Hornick PI, Mason PD, Yacoub MH, Rose ML, Batchelor R, Lechler RI: Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation 97: 1257-1263, 1998
3. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI: Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy. J Immunol 167: 7199-7206, 2001
4. Marelli-Berg FM, Weetman A, Frasca L, Deacock SJ, Imami N, Lombardi G, Lechler RI: Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells. J Immunol 159: 5853-5861, 1997
5. Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB: Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 5: 1298-1302, 1999
6. Wells AD, Li XC, Li Y, Walsh MC, Zheng XX, Wu Z, Nunez G, Tang A, Sayegh M, Hancock WW, Strom TB, Turka LA: Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 5: 1303-1307, 1999
7. Beverly B, Kang SM, Lenardo MJ, Schwartz RH: Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 4: 661-671, 1992
8. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Lechler RI: The role of the allograft in the induction of donor-specific T cell hyporesponsiveness. Transplantation 72: 480-485, 2001
9. Jenkins MK, Schwartz RH: Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165: 302-319, 1987
10. Qin SX, Cobbold S, Benjamin R, Waldmann H: Induction of classical transplantation tolerance in the adult. J Exp Med 169: 779-794, 1989
11. Chai JG, Bartok I, Chandler P, Vendetti S, Antoniou A, Dyson J, Lechler R: Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol 29: 686-692, 1999
12. Orosz CG, Bishop DK: Limiting dilution analysis of alloreactive T-cell status and distribution during allograft rejection. Hum Immunol 28: 72-81, 1990
13. Lenardo MJ: Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353: 858-861, 1991
14. Van Parijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 280: 243-248, 1998
15. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI: Human CD4(+)CD25(+) cells: A naturally occurring population of regulatory T cells. Blood 98: 2736-2744, 2001
16. Arnold B, Schonrich G, Hammerling GJ: Multiple levels of peripheral tolerance. Immunol Today 14: 12-14, 1993
17. Korb LC, Mirshahidi S, Ramyar K, Sadighi Akha AA, Sadegh-Nasseri S: Induction of T cell anergy by low numbers of agonist ligands. J Immunol 162: 6401-6409, 1999
18. Steenbakkers PG, Boots AM, Rijnders AW: T-cell anergy induced by clonotype-specific antibodies: Modulation of an autoreactive human T-cell clone in vitro. Immunology 96: 586-594, 1999
19. Salom RN, Maguire JA, Hancock WW: Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production. Transplantation 56: 1309-1314, 1993
20. Van Gool SW, de Boer M, Ceuppens JL: The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction. J Exp Med 179: 715-720, 1994
21. Willems F, Andris F, Abramowicz D, Pierard G, Wissing M, Leo O, Goldman M: Induction of T-cell anergy by OKT3 requires cyclosporine-insensitive activation signals. Transplant Proc 27: 1425-1427, 1995
22. Yi-qun Z, Lorre K, de Boer M, Ceuppens J: B7-blocking agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory T cells. J Immunol 158: 4734-4740, 1997
23. Masroor S, Itescu S, Artrip JH, Minanov OP, Buelow R, Michler RE: Induction of tolerance in rodent cardiac allotransplantation using an MHC class I-derived peptide and cyclosporin A. Ann Thorac Surg 65: 144-148, 1998